🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

69 results for “NAC” Clear

  1. evinacumab

    EVKEEZA Ultragenyx UK Limited

    EMA: approved

    C10AX

  2. evinacumab-dgnb

    EVKEEZA Regeneron UK Limited

    INJECTION FDA: approved

  3. fidanacogene elaparvovec

    BEQVEZ (PREVIOUSLY DURVEQTIX)

    EMA: withdrawn

  4. gabapentin enacarbil

    HORIZANT

    ORAL FDA: approved

  5. hepatitis a (inactivated) and hepatitis b (rdna) (hab) vaccine (adsorbed)

    AMBIRIX

    EMA: approved

    J07BC20

  6. inactivated

    NMPA: clinical trials

  7. influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted)

    PANDEMRIX

    EMA: unknown

    J07BB02

  8. influenza vaccine (h1n1)v (whole virion, vero cell derived, inactivated)

    CELVAPAN

    EMA: withdrawn

    J07BB01

  9. influenza vaccine (split virion, inactivated)

    INTANZA

    EMA: withdrawn

    J07BB02

  10. influenza vaccine (surface antigen, inactivated, adjuvanted)

    FLUAD TETRA

    EMA: approved

    J07BB02

  11. influenza vaccine (surface antigen, inactivated, prepared in cell cultures)

    FLUCELVAX

    EMA: approved

    J07BB02

  12. influenza vaccine h1n1v (surface antigen, inactivated, adjuvanted)

    FOCETRIA

    EMA: unknown

    J07BB02

  13. japanese encephalitis vaccine (inactivated, adsorbed)

    IXIARO

    EMA: approved

    J07BA02

  14. lenacapavir

    SUNLENCA

    SUBCUTANEOUS FDA: approved · EMA: approved

    J05AX31

  15. lenacapavir sodium

    SUNLENCA

    SUBCUTANEOUS FDA: approved

  16. levomilnacipran

    LEVOMILNACIPRAN

    ORAL FDA: approved

  17. levomilnacipran hydrochloride

    LEVOMILNACIPRAN HYDROCHLORIDE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  18. linaclotide

    CONSTELLA

    ORAL FDA: approved · EMA: approved · NMPA: clinical trials

    A06AX04

  19. lucinactant

    SURFAXIN

    INTRATRACHEAL FDA: approved

  20. milnacipran

    IMPULSOR

    EMA: refused

  21. milnacipran hydrochloride

    MILNACIPRAN HYDROCHLORIDE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  22. nacl

    NMPA: clinical trials

  23. nepafenac

    NEVANAC

    OPHTHALMIC FDA: approved · EMA: approved

    S01BC10

  24. nonacog alfa

    BENEFIX

    EMA: approved

    B02BD04

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources